Casgevy
The MHRA is the first Regulatory body in the world to authorise a Crispr-based gene therapy.
The MHRA is the first Regulatory body in the world to authorise a Crispr-based gene therapy.
With the very sad passing of Her Majesty Queen Elizabeth II, plans are underway for arrangements for primary care services ahead of her funeral on Monday the 19th of September …
In an unprecedented move NHS bosses appeal to the Government to address rising costs before the winter causes a public health emergency.
t National Patient Safety Team, and the British Association of Dermatologists, on the risk of inadvertent oral administration of potassium permanganate and the fear over safety when used.
As early as next year pharmacogenomic tests could be made available on the NHS.
Mobocertinib has now been fast-tracked and will be made available to NHS England eligible lung cancer patients within weeks.